Mirati CEO Steps Down After Going Toe-to-Toe with Amgen in KRAS

Mirati Therapeutics on Tuesday announced that CEO David Meek has resigned from his post, with founder and president Charles Baum taking the company’s reins as it searches for a permanent replacement.